MedTrace Logo

Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis

NCT00097734 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2006-02-14

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy (by assessing the clinical success of treatment) of intravenous antibiotic therapy with ertapenem in patients with acute attacks of sigmoid diverticulitis for 4 vs. 7 days.

Conditions

  • Diverticulitis, Colonic
  • Acute Disease

Interventions

DRUG

ertapenem

Sponsors & Collaborators

  • Klinikum Hanover-Siloah Hospital

    lead OTHER

Principal Investigators

  • Ferdinand Koeckerling, Prof. Dr. · Klinikum Hanover-Siloah hospital and Nordstadt hospital- Surgical Department

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2007-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00097734 on ClinicalTrials.gov